Finotonlimab with chemotherapy in recurrent or metastatic head and neck cancer: a randomized phase 3 trial

作者：Yuankai Shi, Wei Guo, Wei Wang, Yunteng Wu, Meiyu Fang, Xiaoming Huang, Ping Han, Qingyuan Zhang, Dong Pin, Xiaohong Zhou, Hanwei Peng, Chunhong Hu, Xiaopin Chen, Shurong Zhang, Zhiwei Chang, Xiaojiang Li, Yuhai Ding, Song Qu, Shanghua Jing, Songnan Zhang, Lin Gui, Yan Sun, Lin Wang, Yanyan Liu, Hui Wu, Guoqing Li, Zhichao Fu, Jianhua Shi, Hao Jiang, Yuansong Bai, Jiuwei Cui, Yulong Zheng, Wei Cui, Xiaojing Jia, Limin Zhai, Qingqing Cai, Deming Xiong, Yunong Wu, Junning Cao, Rong Wu, G. Hu, Liang Peng, Liangzhi Xie, Wenlin Gai, Yan Wang, Yuehua Su · 发表于：Nature Medicine · 年份：2024 · DOI：10.1038/s41591-024-03110-7 · 被引用次数：32 · 研究领域：Head and Neck Cancer Studies、Lung Cancer Treatments and Mutations、Cancer Diagnosis and Treatment